Augmentation of restless legs syndrome (RLS) under rotigotine: Results from a 5-year prospective, multinational, open-label study

被引：0
|
作者：
Kohnen, R.
Garcia-Borreguero, D.
Benes, H.
Ferini-Strambi, L.
Hoegl, B.
Oertel, W.
Trenkwalder, C.
Fichtner, A.
Schollmayer, E.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1086
引用
收藏
页码：S361 / S361
页数：1
相关论文
共 50 条
  • [21] Gabapentin versus levodopa for the treatment of restless legs syndrome in hemodialysis patients: An open-label study
    Micozkadioglu, H
    Ozdemir, FN
    Kut, A
    Sezer, S
    Saatci, U
    Haberal, M
    RENAL FAILURE, 2004, 26 (04) : 393 - 397
  • [22] SWITCH: An open-label prospective study of switching from pramipexole to ropinirole in RLS
    Mehta, S. H.
    Iyer, S. S.
    Bogan, R. K.
    Jackson, P. D.
    Prakash, R.
    Prozonic, J.
    Morgan, J. C.
    Sethi, K. D.
    MOVEMENT DISORDERS, 2009, 24 : S443 - S444
  • [23] Antibiotic therapy may improve idiopathic restless legs syndrome: Prospective, open-label pilot study of rifaximin, a nonsystemic antibiotic
    Weinstock, Leonard B.
    SLEEP MEDICINE, 2010, 11 (04) : 427 - 427
  • [24] A phase II, open-label, non-comparative study of Botulinum toxin in Restless Legs Syndrome
    Ghorayeb, Imad
    Benard, Antoine
    Vivot, Alexandre
    Tison, Francois
    Burbaud, Pierre
    SLEEP MEDICINE, 2012, 13 (10) : 1313 - 1316
  • [25] Safety and efficacy of long-term treatment with transdermal rotigotine in patients with idiopathic restless legs syndrome: A 12-month open-label extension study
    Benes, H.
    Garcia-Borreguero, H.
    Oertel, W.
    Fichtner, A.
    Schollmayer, E.
    Trenkwalder, C.
    MOVEMENT DISORDERS, 2010, 25 (07) : S515 - S515
  • [26] Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome
    Schneider, Juliane
    Krafft, Alexander
    Manconi, Mauro
    Huebner, Astrid
    Baumann, Christian
    Werth, Esther
    Gyr, Thomas
    Bassetti, Claudio
    SLEEP MEDICINE, 2015, 16 (11) : 1342 - 1347
  • [27] Rotigotine patch efficacy and safety in the treatment of moderate to severe restless legs syndrome - results from a multi-national, long-term, open-label, multi-center trial
    Stiasny-Kolster, K.
    Garcia-Borreguero, D.
    Poewe, W.
    Trenkwalder, C.
    Tacken, I.
    Schollmayer, E.
    Oertel, W. H.
    JOURNAL OF SLEEP RESEARCH, 2006, 15 : 179 - 179
  • [28] Open label comparative study on the efficacy of pramipexole (PMX) vs. ropinirole (RPN) for the treatment of restless legs syndrome (RLS)
    Galvez-Jimenez, N
    Lampuri, C
    Locker, GA
    Hanson, MR
    Smolley, L
    Hargreave, MJ
    MOVEMENT DISORDERS, 2002, 17 : S333 - S333
  • [29] A 52-week, open-label study to assess the long-term tolerability of ropinirole CR extended release tablets in subjects with restless legs syndrome (RLS)
    Hill-Zabala, C.
    Bogan, R.
    Lee, D.
    Lomax, M.
    MOVEMENT DISORDERS, 2008, 23 (01) : S363 - S364
  • [30] Azathioprine in refractory sprue:: Results from a prospective, open-label study
    Mauriño, E
    Niveloni, S
    Cherñavsky, A
    Pedreira, S
    Mazure, R
    Vazquez, H
    Reyes, H
    Fiorini, A
    Smecuol, E
    Cabanne, A
    Capucchio, M
    Kogan, Z
    Bai, JC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (10): : 2595 - 2602
12345